<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04255485</url>
  </required_header>
  <id_info>
    <org_study_id>SH9H-2019-T19-2</org_study_id>
    <nct_id>NCT04255485</nct_id>
  </id_info>
  <brief_title>The Neurobehavioral Effects of Anesthetics on Infants With Hearing Impairment</brief_title>
  <official_title>Long Term Neurobehavioral Effects of Anesthetics and Cochlear Implantation on Infants With Hearing Impairment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The long-term effect of general anesthesia on developing brain is the focus of clinicians
      when infants exposed to general anesthesia for a long time during operation. A retrospective
      study showed that children exposed to long-term or repeated operations, the anesthetics had a
      higher incidence of cognitive impairment in adolescence than those did no. When infants with
      hearing impairment undergo bilateral cochlear implant surgery, they are at high risk of
      long-term neurobehavioral abnormalities caused by anesthesia. In this study, investigators
      intend to observe the long-term behavioral abnormalities of hearing-impaired infants after
      unilateral or bilateral cochlear implantation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change of Baseline Gesell Developmental Scale after 6 month</measure>
    <time_frame>change in 6 months after surgery</time_frame>
    <description>Neurobehavior effects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of Baseline Gesell Developmental Scale after 12 month</measure>
    <time_frame>change in 12 months after surgery</time_frame>
    <description>Neurobehavior effects</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Long Term Neurobehavioral Effects</condition>
  <arm_group>
    <arm_group_label>Short time anesthesia group</arm_group_label>
    <description>Unilateral cochlear implantation,which time of anesthesia is less than 3 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long time anesthesia group</arm_group_label>
    <description>Bilateral cochlear implantation, which time of anesthesia is more than 3 hours</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Children undergoing cochlear implantation under general anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Infants aged between 6 months and 2 years old undergoing cochlear implantation under
             general anesthesia in 9th hospital

          2. Patients who have not participated in other clinical trials

          3. ASA class I-II selective operation without any acute infectious diseases or systematic
             diseases

          4. Infant's family members agree to participated in the trials and sign the informed
             consent

        Exclusion Criteria:

          1. Reject to sign the informed consent and participate in the trials

          2. Patients with severe liver and kidney damage or other heart, lung and nervous system
             diseases

          3. The Gesell developmental scale is less than 86 in motor behavior and physical energy

          4. With a history of intrauterine distress, umbilical cord around the neck, hypoxia and
             jaundice

          5. Infant who is allergic to egg and milk

          6. Family history of malignant hyperthermia

          7. Allergy to anesthetic drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>2 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jingjie Li, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai No.9 People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jingjie Li, M.D</last_name>
    <phone>86-18019790516</phone>
    <email>116212@sh9hospital.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lei Zhang, Ph.D</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai No.9 People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingjie Li, M.D</last_name>
      <phone>18019790516</phone>
      <email>116212@sh9hospital.org</email>
    </contact>
    <contact_backup>
      <last_name>Hong Jiang, Prof.</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 26, 2020</study_first_submitted>
  <study_first_submitted_qc>January 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>March 5, 2020</last_update_submitted>
  <last_update_submitted_qc>March 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</investigator_affiliation>
    <investigator_full_name>Jingjie Li</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>infant</keyword>
  <keyword>anesthesia</keyword>
  <keyword>neurobehavioral development</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 12, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/85/NCT04255485/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

